跳至主要内容
临床试验/NCT04255966
NCT04255966进行中(未招募)不适用

Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Aesculap AG8 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年4月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Aesculap AG
入组人数
60
试验地点
8
主要终点
Harris Hip Score (Functional results of the operated hip) over time

研究概览

简要总结

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Plasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

干预措施: Plasmafit® Revision Structan® (Device)

结局指标

主要结局

Harris Hip Score (Functional results of the operated hip) over time

时间窗: up to five years postoperatively

The functional results of the operated hip will be assessed with the Harris Hip Score (HHS) and evaluated over time

次要结局

  • Radiological Assessment: Osseointegration of the cup over time(at 3 months, 24 months, 5 years follow-up)
  • Impingement(Intraoperative)
  • Complications(up to 5 years postoperatively)
  • Technical problems during surgery(Intraoperative)
  • Quality of Life over time(up to five years postoperatively)
  • Radiological assessment: Radiographic loosening of the cup over time(at 3 months, 24 months, 5 years follow-up)
  • General handling of instruments / containers(Intraoperative)
  • Survival of the implant(up to five years postoperatively)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验